PRS23 Pharmacoeconomic Analysis of Roflumilast for Treatment of Adult Patients With Severe-to-Very Severe Chronic Obstructive Pulmonary Disease (COPD)
Abstract
Authors
A. Margieva V. Omelyanovsky M. Avxentyeva I. Krysanov N. Zorin N. Andreyeva